• Metformin significantly reduces HbA1c and fasting blood glucose in T2DM patients.
• Adverse events are primarily gastrointestinal and mild.
• Metformin is effective as a first-line therapy for T2DM.
• Long-term use of metformin is safe and well-tolerated.